Literature DB >> 3813933

Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy.

M Wall, D George.   

Abstract

Visual field examinations were performed serially on 20 patients with pseudotumor cerebri using a modified Armaly-Drance visual field strategy with a Goldmann perimeter as well as an automated perimeter (Octopus). Visual loss was found in 75% of eyes using the manual strategy and in 77.5% of eyes with automated threshold perimetry. This incidence of visual loss is 50% greater than any previously reported series. All major defects detected were present with both types of perimetry. Both strategies were more sensitive for documenting visual loss than previously described strategies. Since therapy for pseudotumor cerebri is determined by the degree and progression of visual loss, a specific sensitive strategy, rather than routine screening perimetry, should be used for determination of visual loss.

Entities:  

Mesh:

Year:  1987        PMID: 3813933     DOI: 10.1001/archneur.1987.00520140040015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  16 in total

1.  Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome.

Authors:  M L R Monteiro; C L Afonso
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

2.  Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response.

Authors:  Jason C Park; Heather E Moss; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2017-11-14       Impact factor: 2.379

3.  Pseudotumor cerebri: clinical and neuroradiological findings.

Authors:  K Wessel; A Thron; D Linden; D Petersen; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

4.  Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

Review 5.  Space Flight-Associated Neuroocular Syndrome, Idiopathic Intracranial Hypertension, and Pseudotumor Cerebri: Phenotypic Descriptions, Pathogenesis, and Hydrodynamics.

Authors:  Hassan Kesserwani
Journal:  Cureus       Date:  2021-03-25

6.  Optic nerve diameters and perimetric thresholds in idiopathic intracranial hypertension.

Authors:  T Salgarello; C Tamburrelli; B Falsini; A Giudiceandrea; A Colotto
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

7.  Idiopathic intracranial hypertension: clinical features in Chinese patients.

Authors:  I-Hsien Liu; An-Guor Wang; May-Yung Yen
Journal:  Jpn J Ophthalmol       Date:  2011-03-13       Impact factor: 2.447

Review 8.  An update on idiopathic intracranial hypertension.

Authors:  Matthew J Thurtell; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2010 Spring-Summer

9.  Idiopathic intracranial hypertension.

Authors:  Michael Wall
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

10.  Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension.

Authors:  D A Mulholland; J J Craig; S J Rankin
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.